Dr. Gabor Toth, MD
Neurology (Vascular Neurology Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 117
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Neurology Physician primary
OH license 35.095955
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cleveland Clinic Cleveland, OH
- Fairview Hospital Cleveland, OH
Medical groups
- Cleveland Clinic (7,090 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 117
- Services billed
- 346
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | 44 |
| Ultrasonic guidance for blood vessel access | 40 | 36 |
| Established patient office or other outpatient visit, 20-29 minutes | 30 | 26 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 29 | 28 |
| New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | 27 | 27 |
| Established patient office or other outpatient visit, 30-39 minutes | 22 | 22 |
| Review by radiologist of image for insertion of material to block blood flow | 21 | 20 |
| Occlusion of central nervous system or spinal cord artery | 21 | 20 |
| Imaging of blood vessel | 20 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 4 companies reported 21 payments worth $13,049 in total to this clinician.
| Penumbra, Inc. | $10,108 |
|---|---|
| Microvention, Inc. | $2,425 |
| Medtronic, Inc. | $465 |
| Route 92 Medical, Inc. | $50.78 |
| Compensation for services other than consulting (speaking, faculty) | $8,400 |
|---|---|
| Travel and Lodging | $3,652 |
| Food and Beverage | $697 |
| Consulting Fee | $300 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Penumbra, Inc. Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) Penumbra System · Neurointervention | $8,400 |
| Microvention, Inc. Feb 19, 2025 | Travel and Lodging SOFIA 6F-131CM STR; CHAPERON GUIDING CATHETER; WEB ANEURYSM EMBOLIZATION SYSTEM · NEUROLOGICAL PRODUCT · travel to ALISO VIEJO, CA · in-kind | $1,214 |
| Penumbra, Inc. Feb 27, 2025 | Travel and Lodging Penumbra System · Neurointervention · travel to Los Angeles, CA | $833 |
| Microvention, Inc. Jun 4, 2025 | Travel and Lodging travel to PEPPER PIKE, OH | $759 |
| Medtronic, Inc. Dec 18, 2025 | Consulting Fee PIPELINE · Flow Diversion | $300 |
| Penumbra, Inc. Feb 27, 2025 | Travel and Lodging Penumbra System · Neurointervention · travel to Los Angeles, CA | $296 |
| Penumbra, Inc. Mar 1, 2025 | Travel and Lodging Penumbra System · Neurointervention · travel to Los Angeles, CA | $183 |
| Microvention, Inc. Apr 29, 2025 | Travel and Lodging SOFIA 6F-131CM STR; CHAPERON GUIDING CATHETER; WEB ANEURYSM EMBOLIZATION SYSTEM · NEUROLOGICAL PRODUCT · travel to ALISO VIEJO, CA · in-kind | $147 |
| Microvention, Inc. May 1, 2025 | Travel and Lodging SOFIA 6F-131CM STR; CHAPERON GUIDING CATHETER; WEB ANEURYSM EMBOLIZATION SYSTEM · NEUROLOGICAL PRODUCT · travel to ALISO VIEJO, CA · in-kind | $144 |
| Penumbra, Inc. Mar 19, 2025 | Travel and Lodging Penumbra System · Neurointervention · travel to Los Angeles, CA | $75.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $279,583 in research payments for these studies, mostly to the institutions running them.
- REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
Microvention, Inc. · Completed · NCT04451525 - Ruptured Aneurysms Treated With Hydrogel Coils
Microvention, Inc. · Status unknown · NCT03252314 - Safety, Performance and Lesion Evaluation of Neurothrombectomy using CEREGLIDE 92 Intermediate Catheter: A Prospective Multi-Center Single-Arm IDE Trial
Medical Device Business Services, Inc. - Shield US PAS
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.